Wird geladen...
Stem cells and regenerative therapies for Parkinson’s disease
Currently the mainstay of Parkinson’s disease (PD) therapy is the pharmacological replacement of the loss of the dopaminergic nigrostriatal pathway using drugs such as dopamine agonists and levodopa. Whilst these drugs effectively ameliorate some of the motor features of PD, they do not improve many...
Gespeichert in:
| Veröffentlicht in: | Degener Neurol Neuromuscul Dis |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065567/ https://ncbi.nlm.nih.gov/pubmed/30890881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S16087 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|